BridgeBio Pharma, Inc. Q3 FY2024 Earnings Call

BridgeBio Pharma, Inc. (BBIO)

Earnings Call FY2024 Q3 Call date: 2024-11-23 Concluded

Quarter scorecard

Revenue

$2.73M

-33.2% YoY

Diluted EPS

$-0.86

Net income

-$164.25M

License And Service $2.73M

Product $0

Royalty $0